Lung Cancer Symposium – Early Diagnosis & Screening, Benchmarking the Nordics
You are invited to join the second Nordic Lung Cancer Symposium.
Join this symposium and take part in discussions with experts as they frame the challenges of lung cancer and address clinical models for risk prediction, early diagnosis and screening plans in the Nordics. International experts from the UK and USA will share up-to-date experiences from their respective countries. A panel discussion will include implementation models for selection and CT screening.
If you would like at attend digitally, click here to register
Tentative Program
| 10:00–10:10 | Welcome / Introductions Charlotte Homme, Head of Membership & Events, Oslo Cancer Cluster (Confirmed) Ole Alexander Opdalshei, Deputy Secretary General, Norwegian Cancer Society (Confirmed) |
| 10:10–10:30 | The challenges and benefits of lung cancer screening Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway. Lung Symposium, Chair, moderator. (Confirmed) |
| 10:30–11:00 | Lung Cancer Screening: Lessons from the United Kingdom David Baldwin, MD, PhD, Professor, Nottingham University Hospital. Nottingham, UK (Confirmed) |
| 11:00–11:30 | Finland – Efforts and progress in lung cancer screening Jussi Koivunen, MD, PhD, Professor, Department of Oncology and Radiotherapy, The Oulu University Hospital, Oulu, Finland (Confirmed, Digital Live) |
| 11:30–12:30 | Cultural and Networking Lunch |
| 12:30 – 13:00 | Sweden – Efforts and progress in lung cancer screening Bengt Bergman, MD, PhD, Associate Professor, Gothenburg University, National Working Group for Lung Cancer Care, Sweden (Confirmed) |
| 13:00 – 13:30 | Denmark – Efforts and progress in lung cancer screening, and the PLUS Project Michael Stenger, MD, PhD, Associate Professor, PLUS Project Director, Svendborg Hospital, Odense, Denmark (Confirmed) |
| 13:30 – 14:15 | Norway – E-Lung Study, Innovative Models for Screening Selection and Smoking Cessation Progress Report and The TIDL Study. Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway (Confirmed) Toai Duc Nguyen, MD, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway (Confirmed) Trond-Eirik Strand, Associate Professor, Special Advisor, University of Oslo, Oslo, (Confirmed) |
| 14:15 – 14:30 | Coffee Break |
| 14:30 – 15:00 | Lung Cancer Screening in the United States: What Works, What Doesn’t Florian Fintelmann, MD, Associate Professor, Massachusetts General Hospital, Boston (Confirmed, Digital) |
| 15:00 – 16:00 | Panel Discussion and Conclusions: This is the right time to implement lung cancer screening in Norway Panelists, All speakers, plus stakeholders. |
The symposium is:
Organized by: Oslo Cancer Cluster & Levanger Hospital, Norwegian University of Science & Technology
Sponsored by: AstraZeneca & Daiichi Sankyo
Register to attend In Person below
If you would like at attend digitally, click here to register
